Efficacy and safety of early treatment with sarilumab in hospitalised adults with COVID-19 presenting cytokine release syndrome (SARICOR STUDY): protocol of a phase II, open-label, randomised, multicentre, controlled clinical trial

by | Jan 1, 2020 | Publicaciones - DE-02 | 0 comments

Lopez, RL; Fernandez, SC; Perez, LL; Palacios, AR; Fernandez-Roldan, MC; Alonso, EA; Camacho, IP; Rodriguez-Bano, J; Merchante, N; Olalla, J; Esteban-Moreno, MA; Santos, M; Luque-Pineda, A; Torre-Cisneros, J – 2020